WITHDRAWN: Pediatric Giant Craniopharyngioma: Surgical Field Soak in Diluted Nimodipine Solution Reduces Cerebral

Ying Yu1, Zeping Dong1, Dawei Chen1

  • 1Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.

World Neurosurgery
|June 23, 2020
PubMed

Insights

This study reports the largest craniopharyngioma case ever documented. Successful surgical removal was achieved, and nimodipine infusion effectively resolved post-operative vasospasm.

Area of Science:

  • Neuro-oncology
  • Pediatric Neurosurgery

Background:

  • Craniopharyngioma represents a significant portion of pediatric intracranial tumors.
  • These tumors are typically slow-growing and benign.

Observation:

  • A giant cystic craniopharyngioma, measuring 9.2 x 8.7 x 7.0 cm with calcification, was identified in the suprasellar cistern.
  • This case represents the largest craniopharyngioma documented in medical literature.
  • Post-surgical vasospasm occurred in the operative field.

Findings:

  • Surgical removal of the giant craniopharyngioma was completed.
  • Topical application of diluted nimodipine solution reversed the vasospasm, including in the optic nerve and middle cerebral artery.
  • Three-month follow-up showed no residual tumor or recurrence, with only minor subdural hygroma.

Implications:

  • Highlights the successful management of exceptionally large craniopharyngiomas in pediatric patients.
  • Demonstrates the efficacy of nimodipine in managing surgical vasospasm in neurosurgery.
  • Provides a benchmark for surgical outcomes in pediatric craniopharyngioma cases.

Related Concept Videos